Key result
Visit-to-visit variability of systolic blood pressure was associated with increased risks of CVD and mortality, with a 3.4% risk increase for the composite outcome per 1 SD increase in SBP variability.
Why the study?
Does higher visit-to-visit variability of systolic blood pressure increase the risk of cardiovascular disease and mortality in primary care Chinese patients with type 2 diabetes?
Cohort (n=124,105)
Does higher visit-to-visit variability of systolic blood pressure increase the risk of cardiovascular disease and mortality in primary care Chinese patients with type 2 diabetes?
Effect estimate: 3.4% increase (95% CI 3.0-3.8)
Visit-to-visit variability of systolic blood pressure, independent of mean SBP, is a significant predictor of incident cardiovascular disease and all-cause mortality in patients with type 2 diabetes.
May aid risk stratification in T2DM primary care; hypothesis-generating for variability-targeted interventions.
OBJECTIVE: This study aimed to evaluate the impact of visit-to-visit variability (VVV) of systolic blood pressure (SBP) on cardiovascular disease (CVD) and mortality among primary care Chinese patients with type 2 diabetes mellitus (T2DM). RESEARCH DESIGN AND METHODS: A retrospective cohort study was conducted in 124,105 Chinese adult primary care patients with T2DM and without prior diagnosed CVD from August 2008 to December 2009. The VVV of SBP was evaluated using SDs of SBP over 24 months. The risks of CVD and all-cause mortality associated with variability in SBP were evaluated using Cox proportional hazards regression. Subgroup analysis was conducted by the stratification of age, sex, duration of diabetes, the presence of chronic kidney disease, baseline SBP and trend, and the number and class of antihypertensive drugs. RESULTS: A positive linear relationship between the VVV of SBP and the first incidence of CVD and all-cause mortality was identified over a median follow-up time of 39.5 months. Patients with a low SD of SBP of <5 mmHg had the lowest risks of CVD and all-cause mortality, and patients with an SD of SBP of ≥10 mmHg had significantly higher risks. For every 1 SD increase in the SD of SBP, the risks of CVD, all-cause mortality, and the composite of both events increased by 2.9% (95% CI 2.4-3.4%), 4.0% (95% CI 3.5-4.6%), and 3.4% (95% CI 3.0-3.8%), respectively. A direct linear relationship was also observed in all selected subgroups. CONCLUSIONS: SBP variability, irrespective of the mean SBP level, is a potential predictor for the development of CVD and all-cause mortality in patients with diabetes. In addition to monitoring BP targets for their patients with diabetes, clinicians should also remain vigilant about the visit-to-visit fluctuation of BP.
No takes yet. Share an insight, caveat, or question.
Wan et al. (2016) conducted a cohort in Type 2 diabetes mellitus (n=124,105). Visit-to-visit variability of systolic blood pressure vs. Low SD of SBP (<5 mmHg) was evaluated on Composite of first incidence of CVD and all-cause mortality (3.4% increase, 95% CI 3.0-3.8). Visit-to-visit variability of systolic blood pressure was associated with increased risks of CVD and mortality, with a 3.4% risk increase for the composite outcome per 1 SD increase in SBP variability.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: